Norma Skolnik has over 35 years of regulatory experience working with the pharmaceutical and dietary supplement industries. She served as Director of Regulatory Affairs for the Americas for Cadbury Adams. Prior to that she was Director of Regulatory Affairs for the Adams Division of Pfizer and Associate Director Of Regulatory Affairs for the Warner-Lambert company. She also served as Director of Regulatory Affairs for Lederle Consumer Healthcare and as Associate Director of Marketed Product Support for Lederle Laboratories and Associate Director of Regulatory Affairs for Wyeth.

Upcoming Webinars by this speaker Recorded Webinars by this speaker Back to Our Speaker
Norma Norma

Speaker: Norma Skolnik
Duration: 60 Minutes
Product ID: 700412

Purchase

How the FDA & FTC Regulate Advertising & Promotion of Drugs & Dietary Supplements

This webinar will cover FDA regulatory compliance training requirements for all manufacturers and distributors who want to advertise and/or promote OTC drugs list and dietary supplements in the U.S more...

Norma Norma

Speaker: Norma Skolnik
Duration: 60 Minutes
Product ID: 700374

Purchase

U.S. Adverse Event Reporting Regulations for Drugs, Dietary Supplements & Cosmetics

In order to market dietary supplements and OTC drugs list in the U.S., reporting serious adverse events is required. more...

Norma Norma

Speaker: Norma Skolnik
Duration: 60 Minutes
Product ID: 700308

Purchase

How the FDA & FTC Regulate Advertising & Promotion of Drugs & Dietary Supplements

This webinar will cover FDA regulatory compliance training requirements for all manufacturers and distributors who want to advertise and/or promote OTC drugs list and dietary supplements in the U.S more...

Norma Norma

Speaker: Norma Skolnik
Duration: 60 Minutes
Product ID: 700172

Purchase

FDA Regulations for Marketing OTC Drugs in the U.S.

The webinar will offer an overview of FDA requirements for marketing, labelling and promotion of OTC drugs in the U.S. It will cover how OTC pharmacy can be effectively marketed and the OTC Monogra more...